Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357704

Medchemexpress LLC Gefitinib hydrochloride | 184475-55-6 | 99.8% | 500 MG
SDP

Catalog No. 5000357704
Encompass_Preferred

Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective, and orally active inhibitor of EGFR tyrosine kinase, with an IC50 of 33 nM. It specifically inhibits EGF-stimulated tumor cell growth with an IC50 of 54 nM and blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Additionally, Gefitinib hydrochloride has been shown to induce autophagy and possesses antitumour activity.

  • Potent, selective, and orally active EGFR tyrosine kinase inhibitor.
  • Inhibits EGF-stimulated tumor cell growth.
  • Blocks EGF-stimulated EGFR autophosphorylation in tumor cells.
  • Induces autophagy.
  • Demonstrates antitumour activity.

Catalog No. 50-003-57704 Supplier Medchemexpress LLC Supplier No. HY50895A500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective, and orally active inhibitor of EGFR tyrosine kinase, with an IC50 of 33 nM. It specifically inhibits EGF-stimulated tumor cell growth with an IC50 of 54 nM and blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Additionally, Gefitinib hydrochloride has been shown to induce autophagy and possesses antitumour activity.

  • Potent, selective, and orally active EGFR tyrosine kinase inhibitor.
  • Inhibits EGF-stimulated tumor cell growth.
  • Blocks EGF-stimulated EGFR autophosphorylation in tumor cells.
  • Induces autophagy.
  • Demonstrates antitumour activity.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.